2015-os idegen nyelvű publikációk

  • Ivády G, Koczok K, Madar L, Gombos É, Tóth I, Győri K, Balogh I. Molecular analysis of cystic fibrosis patients in hungary – an update to the mutational spectrum. J Med Biochem. (2015) 34: 46–51.
  • Árokszállási A, Kerényi A, Katona É, Bereczky Z, Muszbek L, Boda Z, Schlammadinger Á. The use of recombinant factor XIII in a major bleeding episode of a patient with congenital FXIII deficiency – thr first experience. Haemophilia  (2015) 21.118-121.
  • Ilonczai P, Oláh Z, Selmeczi A, Kerényi A, Bereczky Z, Póka R, Schlammadinger Á, Boda Z. Management and outcome of pregnancies in women with antithrombin deficiency: a single center experience and review of literature. Blood Coagul Fibrinolysis (2015) 26(7):798-804.
  • Lőrincz H, Harangi M, Oláh AV, Szabó GP, Fülöp P, Somodi S, Paragh G, Seres I: Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome. Pediatric Research (2015) 77, 703-709.
  • Gáspár K, Baráth S, Nagy G, Mócsai G, Gyimesi E, Szodoray P, Irinyi B, Zeher M, Remenyik E, Szegedi A. Regulatory T-cell Subsets in Atopic Dermatitis: Important Indicators of Disease Severity with Acquired Functional Impairment. Acta Derm Venereol. (2015) 95: 151-155
  • Papp G, Horvath IF, Gyimesi E, Barath S, Vegh J, Szodoray P, Zeher M. The assesment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study. Immunol. Res. (2015) PMID: 26168768
  • E. Polonkai, E. Gyimesi,  I. Kovács,  A. Csillag,  Gy. Balla,  É. Rajnavölgyi, A. Bácsi, S. Sipka . A possible role of elevated breast milk lactoferrin and the cytokine IL-17 levels in predicting early allergy in infants: A pilot study  Acta Alimentaria (2015) DOI: 10.1556/AAlim.2015.0001
  • Mócsai G, Gáspár K, Dajnoki Z, Tóth B, Gyimesi E, Bíró T, Maródi L, Szegedi A. Investigation of skin barrier functions and allergic sensitization in patients with hyper-IgE syndrome.  J. Clin. Immunol. (2015)  35: 681-688
  • Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. J Crohns Colitis. (2015) Oct;9(10):891-8. doi: 10.1093/ecco-jcc/jjv127.
  • Kulcsar-Jakab E, Petho Z, Pap Z, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P, Bhattoa HP. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. BMC Musculoskelet Disord. (2015) Aug 28;16:227. doi: 10.1186/s12891-015-0684-1.
  • Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]. J Crohns Colitis. (2015) Aug;9(8):659-68. doi: 10.1093/ecco-jcc/jjv087.
  • Kappelmayer J, Antal-Szalmás P, Nagy B Jr. Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders. Clin Chim Acta. 2015 Jan 1;438:35-42. doi: 10.1016/j.cca.2014.07.040.
  • N. Sipeki, L. Davida, E. Palyu, I. Altorjai, J. Harsfalvi, P. Antal-Szalmas, Z. Szabo, G. Veres, Z. Shums, GL. Norman, PL. Lakos, M. Papp: Prevalence; significance and predictive value of antiphospholipid antibodies (APLA) in Crohn’s disease. World Journal of Gastroenterology (2015) 21:6952-6964.
  • Szántó A, Szabó K, Nagy G, Molnár C, Zeher M. Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren’s Syndrome. Pathol Oncol Res. (2016) Jan 19. [Epub ahead of print]
  • Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L. Factor XIII B subunit polymorphisms and the risk of coronary artery disease. Int J Mol Sci. (2015) Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143.
  • Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke. Blood Coagul Fibrinolysis. (2014) Jun;25(4):364-8. doi: 10.1097/MBC.0000000000000055.
  • Nagy T, Paszti E, Kaplar M, Bhattoa HP, Goth L. Further acatalasemia mutations in Hungarian patients with diabetes and microcytic anemia. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.(2015) 772:10–14. doi:10.1016/j.mrfmmm.2014.12.008
  • Petho Z, Kulcsar-Jakab E, Kalina E, Balogh A,Pusztai A, Gulyas K, Horvath A, Szekanecz Z, Bhattoa HP. Vitamin D status in men with psoriatic arthritis: a case-control study. OsteoporosisInt (2015) 26:1965–1970DOI 10.1007/s00198-015-3069-2
  • Kincse G, Bhattoa PH, Herédi E, Varga J, Szegedi A, Kéri J, Gaál J. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol (2015) May 11. doi: 10.1111/1346-8138.12876.
  • Karras SN, Annweiler C, Boucher B, Bhattoa HP, Muscogiuri G, Stefan P. Re: Bias, Bones and Vitamin D. http://www.bmj.com/content/351/bmj.h3170/rr-3. Response to: Grey A, Bolland MJ. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ (2015) 351 doi: http://dx.doi.org/10.1136/bmj.h3170
  • Bodoki L, Chen JQ, Zeher M, Nagy-Vincze M, Griger Z, Zilahi E, Dankó K. Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy. Biomed Res Int. 2015:809895.
  • Horton DL, McElhinney LM, Freuling CM, Marston DA, Banyard AC, Goharrriz H, Wise E, Breed AC, Saturday G, Kolodziejek J, Zilahi E, Al-Kobaisi MF, Nowotny N, Mueller T, Fooks AR. Complex epidemiology of a zoonotic disease in a culturally diverse region: phylogeography of rabies virus in the Middle East. PLoS Negl Trop Dis. 2015 Mar 26;9(3)
  • Chen JQ, Zilahi E, Papp G, Sipka S, Zeher M. Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2015 Dec 1

Frissítés dátuma: 2019.06.27.